Clinical Trials Directory

Trials / Unknown

UnknownNCT05526274

Clinical Epidemiology of NAFLD in Children and Adolescents

Clinical Epidemiology of Non-alcoholic Fatty Liver Disease in Children and Adolescents. The LiverKids Study.

Status
Unknown
Phase
Study type
Observational
Enrollment
2,866 (estimated)
Sponsor
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina · Academic / Other
Sex
All
Age
9 Years – 16 Years
Healthy volunteers
Accepted

Summary

Background: Non-alcoholic fatty liver disease (NAFLD) is rapidly increasing alongside overweight and obesity, not only in adults but also in children and adolescents. It is unknown what impact the development of NAFLD in childhood may have in later life. The importance of early detection and treatment lies in its potential for progression to cirrhosis, liver cancer and liver-related death, as well as its associated extrahepatic comorbidities. Vibration-Controlled Transient Elastography (VCTE) with Controlled Attenuation Parameter (CAP) is an effective, non-invasive and safe diagnostic method to estimate the degree of fibrosis and steatosis in the liver, but little is known about its applicability in the paediatric population. Objectives: 1) To assess the prevalence of significant liver fibrosis (LSM≥6,5kPa) using VCTE, and that of non-alcoholic fatty liver disease (≥225dB/m) using CAP in children and adolescents. 2) To determine the optimal cut-off points of the CAP to achieve maximum concordance with the Magnetic Resonance Imaging (MRI) findings in the diagnosis of mild, moderate and severe NAFLD in children and adolescents. Methods: cross-sectional population-based study which will include 2.866 subjects aged ≥9 to ≤16 years. Participants will undergo: anamnesis, physical examination, blood extraction, VCTE, MRI and questionnaires on socio-demographic data, personal and family medical history and lifestyle assessment. Applicability and relevance: the study aims to establish the foundations for the use of VCTE in children and adolescents in order to achieve early diagnosis of NAFLD. Moreover, it will serve to understand in further detail the disease and to identify the risk groups of children and adolescents who may be at risk of developing it. Ultimately, this will help determine to which subgroups of the population we need to target resources for prevention and early detection of this entity, as well as possible intervention for its treatment.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTVibration-Controlled Transient Elastography (VCTE) with Controlled Attenuation Parameter (CAP)VCTE with associated CAP is an effective, non-invasive and safe diagnostic method to estimate the degree of fibrosis and steatosis in the liver.

Timeline

Start date
2022-10-01
Primary completion
2023-07-01
Completion
2023-12-01
First posted
2022-09-02
Last updated
2022-09-02

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT05526274. Inclusion in this directory is not an endorsement.